Global Keloid Treatment Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Product;
Elastic Wraps and Ointment.By Treatment;
Radiation Therapy, Cry Therapy, Surgical Treatment, Laser Treatment, and Interferon.By End Use;
Hospitals , Dermatology, Clinics, Ambulatory Surgical Centers (ASCs), and Others.By Geography;
North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global Keloid Treatment Market (USD Million), 2021 - 2031
In the year 2024, the Global Keloid Treatment Market was valued at USD 4,468.43 million. The size of this market is expected to increase to USD 6,162.85 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.7%.
Global Keloid Treatment Market Growth, Share, Size, Trends and Forecast
*Market size in USD million
CAGR 4.7 %
Study Period | 2025 - 2031 |
---|---|
Base Year | 2024 |
CAGR (%) | 4.7 % |
Market Size (2024) | USD 4,468.43 Million |
Market Size (2031) | USD 6,162.85 Million |
Market Concentration | High |
Report Pages | 326 |
Major Players
- Novartis AG
- RXi Pharmaceuticals, Inc.
- Sonoma Pharmaceuticals, Inc.
- Bristol-Myers Squibb Company
- Pacific World Corporation
- Valeant Pharmaceuticals International, Inc.
- Revitol Corporation
- Avita Medical Limited
- Sensus Healthcare
- Perrigo Company plc.
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Global Keloid Treatment Market
Fragmented - Highly competitive market without dominant players
The Global Keloid Treatment Market is experiencing steady growth, primarily fueled by the rising number of individuals developing keloid scars due to burns, surgeries, piercings, acne, and other skin traumas. Around 10% of the population, particularly those prone to abnormal wound healing, are at risk of keloid formation. The cosmetic and physical discomfort associated with these scars is increasing the demand for advanced and effective treatment solutions.
Surge in Demand for Minimally Invasive Therapies
Non-invasive and minimally invasive treatment options have become the preferred approach, accounting for over 60% of total procedures in the keloid care market. Therapies such as steroid injections, laser treatment, cryotherapy, and silicone-based applications are widely chosen due to their ease of use, shorter recovery times, and fewer complications. The rising emphasis on aesthetic appearance and patient comfort continues to drive the popularity of these solutions.
Advancements in Treatment Modalities
Continual innovation in keloid therapies is reshaping treatment protocols and outcomes. New drug delivery systems and combination therapies are helping reduce recurrence rates, which remain as high as 50% in conventional treatments. Blending methods—such as laser therapy with corticosteroid injections or radiation post-surgery—are proving more effective, offering patients improved long-term results and higher satisfaction.
Rising Awareness and Improved Access to Care
A growing awareness of treatment availability and the psychological burden of keloids—impacting over 70% of affected individuals’ quality of life—has significantly boosted consultation rates. Patients are increasingly seeking professional care for both physical relief and cosmetic correction. Improved access to dermatological care, supported by expanding healthcare infrastructure, is contributing to higher adoption of these therapies across varied demographics.
Pipeline Developments and Future Outlook
The market’s future is being shaped by promising clinical developments, with nearly 30% of pipeline therapies focused on novel strategies such as gene-targeted treatments and anti-fibrotic agents. These innovations aim to tackle the root causes of keloid formation rather than just addressing symptoms. As clinical trials progress and these new options gain approval, the market is set for sustained and dynamic growth.
Global Keloid Treatment Market Recent Developments
-
In September 2022, AVITA Medical, Inc. achieved a major milestone with the announcement that its RECELL System for the treatment of acute burns had secured insurance coverage in Japan. This development was officially communicated by COSMOTEC, a key member of the M3 Group. The inclusion of RECELL under insurance coverage enhances accessibility to this innovative treatment, which utilizes a patient’s own skin cells to promote healing. This advancement is expected to significantly benefit patients and healthcare providers by offering a cost-effective and clinically efficient burn care solution in the Japanese market.
-
In February 2022, Avita Medical Inc. secured a significant regulatory milestone with the approval of its RECELL System by Japan's Pharmaceuticals and Medical Devices Agency (PMDA). This authorization allows the company to commercially market the RECELL System within Japan, paving the way for broader adoption of its cell-based burn treatment technology. The PMDA's approval highlights the clinical promise of RECELL in accelerating wound healing through the use of autologous skin cell therapy, strengthening Avita Medical’s presence in the advanced wound care sector.
Segment Analysis
In this report, the Global Keloid Treatment Market has been segmented by Product, Treatment, End User, and Geography.
Global Keloid Treatment Market, Segmentation by Product
The Global Keloid Treatment Market has been segmented by Product into Elastic Wraps and Ointment.
Elastic Wraps
Elastic Wraps dominate the keloid treatment market, contributing about 55–60% of the total market. These wraps are essential for providing compression to the affected area, which helps to minimize the appearance of keloids and prevent further growth. Their affordable price point and ease of use have led to widespread popularity.
Ointment
Ointment products account for approximately 40–45% of the market. These topical treatments offer benefits such as reducing inflammation, promoting tissue regeneration, and alleviating discomfort associated with keloid scars. Their availability in both over-the-counter and prescription strengths makes them highly accessible to a broad range of consumers.
Global Keloid Treatment Market, Segmentation by Treatment
The Global Keloid Treatment Market has been segmented by Treatment into Radiation Therapy, Cry Therapy, Surgical Treatment, Laser Treatment, Laser Treatment, and Interferon.
Radiation Therapy
Radiation Therapy holds a significant share in the keloid treatment market, contributing about 25–30% of the total market. This treatment is commonly used after surgical excision to prevent recurrence, utilizing low-dose radiation. It is particularly effective for recurrent keloids and large, problematic scars that are difficult to treat.
Cryotherapy
Cryotherapy captures about 15–20% of the market. By applying extreme cold to the keloid, this treatment works by destroying the scar tissue and reducing its size. Its non-invasive nature, along with minimal side effects, contributes to its growing popularity as a treatment option for keloid management.
Surgical Treatment
Surgical Treatment accounts for approximately 20–25% of the keloid treatment market. This approach involves excising the keloid, followed by other therapies like steroids or radiation to minimize recurrence. It remains a common choice for severe keloids that do not respond well to non-surgical treatments.
Laser Treatment
Laser Treatment comprises around 25–30% of the market. It is one of the most sought-after therapies, as it reduces the size, redness, and texture of keloid scars. Fractional lasers and pulsed dye lasers are among the most commonly used types to break down keloid tissue effectively.
Interferon
Interferon accounts for about 5–10% of the market. This treatment uses a protein-based approach to regulate the immune response and reduce collagen production in scar tissue. It is typically used for stubborn, persistent keloids that do not respond to other conventional treatments.
Global Keloid Treatment Market, Segmentation by End User
The Global Keloid Treatment Market has been segmented by End User into Hospitals , Dermatology, Clinics, Ambulatory Surgical Centers (ASCs), and Others.
Hospitals
Hospitals lead the keloid treatment market with a market share of around 40-45%. This large share is attributed to hospitals’ ability to handle complex and severe cases, providing advanced treatments such as surgery, laser therapy, and radiation. Hospitals are the go-to choice for patients requiring intensive care and specialized treatments for keloid scars.
Dermatology Clinics
Dermatology Clinics account for about 30-35% of the market. These clinics are specialized in the diagnosis and treatment of skin conditions, making them a popular option for non-invasive keloid treatments like cryotherapy, laser therapy, and topical ointments. With personalized care and a focus on skin health, dermatology clinics attract patients seeking targeted, effective solutions.
Ambulatory Surgical Centers (ASCs)
Ambulatory Surgical Centers (ASCs) make up around 15-20% of the market share. These centers offer outpatient surgeries, which are more cost-effective and convenient. ASCs are favored for minor surgeries such as keloid removal, making them an appealing option for patients seeking quicker, more affordable procedures outside of a hospital setting.
Others
The Others category, which includes private clinics and home-care options, accounts for about 10-15% of the market. With the rise in at-home treatments and personalized care options, this segment is growing rapidly. Patients are increasingly choosing this flexible option, which offers convenience and accessibility while managing keloids in a less formal setting.
Global Keloid Treatment Market, Segmentation by Geography
In this report, the Global Keloid Treatment Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Keloid Treatment Market Share (%), by Geographical Region, 2024
North AmericaNorth America holds a significant share of the global keloid treatment market, accounting for approximately 30% of the total market. The increasing awareness about keloid scars, coupled with advanced healthcare infrastructure, is driving growth in this region. Additionally, the high adoption of laser treatments and corticosteroid injections contributes to the region's strong market position. With a growing number of clinical trials and technological advancements, North America continues to lead the global market.
EuropeEurope is another key region, contributing around 25% to the global keloid treatment market. The presence of leading healthcare facilities and a well-established dermatology industry fosters market growth. Countries like Germany, the UK, and France are seeing a rising demand for minimally invasive treatments such as cryotherapy and silicone gel sheets. Furthermore, increasing research and development efforts focused on innovative keloid therapies are expected to sustain market expansion in the coming years.
Asia PacificAsia Pacific is rapidly emerging as a strong player in the keloid treatment market, capturing roughly 20% of the market share. Growing awareness about skincare and cosmetic treatments, especially in countries like Japan, China, and India, is driving demand. Additionally, rising disposable incomes and improved access to healthcare services contribute to the region's growth. The popularity of traditional medicine in certain countries also plays a role in the demand for alternative treatment options.
Middle East and AfricaThe Middle East and Africa accounts for approximately 10% of the global keloid treatment market. Factors such as a rising population and increasing urbanization have led to a greater awareness of medical aesthetics. Countries in this region are also investing heavily in healthcare infrastructure, which boosts the availability of advanced treatment options like laser therapy and surgical excisions. Although market penetration is still developing, the demand for keloid treatments is on the rise.
Latin AmericaLatin America contributes to around 15% of the global keloid treatment market. The demand for both surgical and non-surgical treatments has been increasing due to the region's growing aesthetic focus and cosmetic surgery trends. Countries like Brazil and Mexico are experiencing a surge in medical tourism, where patients seek advanced keloid treatments. This is further supported by improved healthcare systems and a larger number of specialists offering various treatment options.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Keloid Treatment Market. These factors include; Market Drivers, Restraints and Opportunities.
Drivers:
- Increasing Keloid Incidence
- Technological Advancements
-
Growing Healthcare Expenditure - This trend is particularly evident in developed regions like North America and Europe, where high healthcare budgets support extensive research and development activities, leading to the introduction of innovative keloid treatment modalities such as advanced laser therapies, cryotherapy, and radiation therapy. These regions benefit from robust healthcare systems that facilitate the adoption of new technologies and treatments, enhancing patient outcomes and satisfaction.
In emerging economies across the Asia Pacific, Latin America, and the Middle East and Africa, rising healthcare expenditure is transforming the market landscape. Countries like China and India are investing heavily in healthcare infrastructure, driven by economic growth and increasing government initiatives to improve public health. This investment is enhancing the availability and accessibility of advanced keloid treatments, contributing to market expansion. As disposable incomes rise and middle-class populations grow, there is an increasing demand for effective and aesthetically pleasing scar management solutions. Improved healthcare access and affordability in these regions are making it possible for more patients to seek treatment for keloid scars, further driving market growth.
The growing healthcare expenditure is fostering a competitive environment among pharmaceutical companies and medical device manufacturers. Increased funding for research and development is leading to the discovery of novel treatments and improving the efficacy and safety of existing therapies. This competitive landscape is resulting in better treatment options for patients and expanding the overall market. Additionally, healthcare policies and insurance coverage in various regions are evolving to include more comprehensive treatment options for conditions like keloids, making advanced treatments more accessible to a broader population.
Restraints:
- High Treatment Costs
- Limited Awareness
-
Side Effects Concerns - Corticosteroid injections, commonly used to reduce inflammation and flatten keloids, can lead to skin atrophy, hypopigmentation, and systemic effects if used extensively. These adverse effects can be particularly concerning for patients with darker skin tones, where pigment changes are more noticeable.
Cryotherapy, which involves freezing the keloid tissue, can result in blistering, pain, and changes in skin pigmentation. These side effects can cause discomfort and cosmetic issues, reducing patient compliance and satisfaction with the treatment. Laser therapy, another popular treatment option, can cause temporary redness, swelling, and in some cases, scarring or changes in skin texture. The risk of these side effects can make patients hesitant to undergo laser treatments, despite their potential effectiveness in reducing keloid size and appearance.
Surgical excision, often considered for larger or more resistant keloids, carries the risk of infection, scarring, and recurrence of the keloid, sometimes in a more severe form. The possibility of keloids returning or worsening after surgery makes this option less appealing for both patients and clinicians. Radiation therapy, used as an adjunct to surgery, can lead to skin irritation, pigmentation changes, and long-term risks such as radiation-induced malignancies, raising significant concerns about its safety.
Opportunities:
- Emerging Market Growth
- Innovative Therapies Development
-
Personalized Medicine Trends - Personalized medicine allows for the identification of specific genetic and molecular markers associated with keloid development, enabling healthcare providers to design treatment plans that are tailored to the patient's unique genetic profile. This approach not only enhances the effectiveness of treatments but also minimizes the risk of adverse effects, as therapies can be chosen based on their compatibility with the patient’s biology. For instance, patients who are genetically predisposed to certain side effects from corticosteroid injections or laser treatments can be directed towards alternative therapies that are safer and more effective for their particular condition.
Personalized medicine opens up the possibility of combining multiple treatment modalities in a synergistic manner, optimizing outcomes by addressing different aspects of keloid pathology simultaneously. For example, a combination of genetic therapy to modulate scar tissue formation, targeted laser therapy to reduce the size and appearance of the keloid, and personalized topical treatments to manage inflammation and skin texture can be devised to provide comprehensive care.
The integration of personalized medicine into keloid treatment is further supported by advancements in technology, such as high-throughput sequencing, bioinformatics, and precision imaging, which facilitate accurate diagnosis and monitoring of treatment efficacy. These technologies enable continuous assessment and adjustment of treatment plans, ensuring that patients receive the most effective and least invasive interventions possible.
Competitive Landscape Analysis
Key players in Global Keloid Treatment Market include:
- Novartis AG
- RXi Pharmaceuticals, Inc.
- Sonoma Pharmaceuticals, Inc.
- Bristol-Myers Squibb Company
- Pacific World Corporation
- Valeant Pharmaceuticals International, Inc.
- Revitol Corporation
- Avita Medical Limited
- Sensus Healthcare
- Perrigo Company plc.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Treatment
- Market Snapshot, By End Use
- Market Snapshot, By Region
- Global Keloid Treatment Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
-
Increasing Incidence
-
Technological Advancements
-
Rising Aesthetic Awareness
-
- Restraints
-
High Treatment Costs
-
Side Effects and Recurrence
-
Limited Insurance Coverage
-
- Opportunities
-
Emerging Markets
-
Innovative Therapies
-
Telemedicine Growth
-
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Keloid Treatment Market, By Product, 2021 - 2031 (USD Million)
-
Elastic Wraps
-
Ointment
-
- Global Keloid Treatment Market, By Treatment, 2021 - 2031 (USD Million)
-
Ligature
-
Radiation Therapy
-
Cryo Therapy
-
Surgical Treatment
-
Laser Treatment
-
Interferon
-
- Global Keloid Treatment Market, By End User, 2021 - 2031 (USD Million)
- Hospitals
- Dermatology
- Clinics
- Ambulatory Surgical Centers (ASCs)
- Others
- Global Keloid Treatment Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Keloid Treatment Market, By Product, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Novartis AG
- RXi Pharmaceuticals, Inc
- Sonoma Pharmaceuticals, Inc
- Bristol-Myers Squibb
- Pacific World Corporation
- Valeant Pharmaceuticals International, Inc
- Revitol Corporation
- Avita Medical Limited
-
Sensus Healthcare
-
Perrigo Company plc.
- Company Profiles
- Analyst Views
- Future Outlook of the Market